Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Miller Thomson LLP
Significant amendments to the federal Food and Drugs Act, which are commonly referred to as "Vanessa’s Law", became law in November, 2014.
Norton Rose Fulbright Canada LLP
On April 20, 2015, the Supreme Court of Canada (SCC) heard Sanofi-Aventis’ appeal of the Federal Court of Appeal section 8 quantification decision with respect to the drug Ramipril.
Gowling Lafleur Henderson LLP
On April 20, 2015, the Supreme Court of Canada dismissed Sanofi-Aventis’ appeal concerning a claim by Apotex for section 8 damages under the Patented Medicines (Notice of Compliance) Regulations.
Norton Rose Fulbright Canada LLP
Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070
MNP
Running a successful and profitable agri-food business in today’s increasingly complex and integrated marketplace is a huge challenge.
McCarthy Tétrault LLP
In reasons dated February 26, 2015, Justice Barnes dismissed Janssen’s application for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for the compound bortezomib.
Torys LLP
Industry Canada has announced that the Patent Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations) will be amended...
Norton Rose Fulbright Canada LLP
Bill C-17, An Act to Amend the Food and Drugs Act (also referred to as the Protecting Canadians from Unsafe Drugs Act), received Royal Assent on November 6, 2014.
Stikeman Elliott LLP
On March 10, 2015, the Standing Senate Committee on Social Affairs, Science and Technology released a final report entitled "Prescription Pharmaceuticals in Canada".
Clark Wilson LLP
The Supreme Court of Canada recently revisited euthanasia, and endorsed a permissive regime that will allow doctor assisted suicide in certain limited cases.
Dickinson Wright PLLC
Back in 2012, the Ontario Court of Appeal recognized the tort of invasion of privacy – fast forward to the recent string of privacy breaches of personal information held by health care facilities in Ontario.
Gowling Lafleur Henderson LLP
The recent legislative amendments gave Health Canada new powers to address health and safety concerns regarding "therapeutic products" (which includes both drugs and medical devices...
Miller Thomson LLP
Significant amendments to the Food and Drugs Act, commonly referred to as "Vanessa’s Law", became law in November, 2014.
Miller Thomson LLP
Significant amendments to the Food and Drugs Act, commonly referred to as "Vanessa’s Law", became law in November, 2014.
Norton Rose Fulbright Canada LLP
Janssen Inc [Janssen] sells infliximab under the brand name REMICADE®.
Jones Day
Health Canada's Food Directorate recently finalized a health claim on the ability of protein-rich soy foods to lower cholesterol.
Miller Thomson LLP
The Ontario government has tabled legislation to amend the province’s production insurance regime and to bring it in-line with other provincial regimes.
Blake, Cassels & Graydon LLP
The grain shipment rules (Rules) enacted by the Canadian government—the most recent iteration of which expired on March 28, 2015—have not been renewed.
Torkin Manes LLP
Barbara MacFarlane discusses what you need to know about a medical malpractice lawsuite as part of the Torkin Manes LegalPoint Video Series.
Torkin Manes LLP
James McLean, an Ontario optician practising in Hamilton, brought a Court application seeking a declaration that his proposed model for obtaining prescriptions, and dispensing eyewear, is lawful.
Latest Video
Most Popular Recent Articles
Moodys Gartner Tax Law LLP
Budget announcements from the Government of Alberta for the last number of years have generally been humdrum events.
Torys LLP
Manufacturers and distributors intending to market their U.S. dietary supplements in Canada will want to understand the regulation of dietary supplements in the U.S.
Gowling Lafleur Henderson LLP
Prince Edward Island, the Northwest Territories and the Yukon have introduced new legislation aimed at protecting personal health information that is expected to come into force sometime in 2015.
McCarthy Tétrault LLP
Although PHIPA was introduced over ten years ago, only one person has ever been charged under the legislation...
Norton Rose Fulbright Canada LLP
Janssen Inc [Janssen] sells infliximab under the brand name REMICADE®.
Miller Thomson LLP
Significant amendments to the Food and Drugs Act, commonly referred to as "Vanessa’s Law", became law in November, 2014.
McCarthy Tétrault LLP
In reasons dated February 26, 2015, Justice Barnes dismissed Janssen’s application for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for the compound bortezomib.
Smart & Biggar/Fetherstonhaugh
Health Canada has recently released a draft Good Label and Package Practices Guide for stakeholder consultation.
Gowling Lafleur Henderson LLP
On April 20, 2015, the Supreme Court of Canada dismissed Sanofi-Aventis’ appeal concerning a claim by Apotex for section 8 damages under the Patented Medicines (Notice of Compliance) Regulations.
Miller Thomson LLP
The Ontario government has tabled legislation to amend the province’s production insurance regime and to bring it in-line with other provincial regimes.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners